Synapticure brings expert virtual care to individuals and caregivers living with neurodegenerative diseases, including Parkinson's, Alzheimer's and related dementia, ALS, and more conditions. Our mission is to democratize access to cutting-edge and personalized care provided by neurologists, mental health providers, and care navigators here for you 24/7.
| Website | https://synapticure.com |
| Revenue | $21 million |
| Employees | 103 (66 on RocketReach) |
| Founded | 2019 |
| Phone | +1 708-872-7108 |
| Industry | Hospitals and Health Care, Healthcare Software, Software Development & Design, Software |
| Keywords | Virtual Care Platform |
| Competitors | Roche, Vertex Pharmaceuticals, Biogen, Eisai Co., Ltd., Alnylam Pharmaceuticals, Neurocrine Biosciences, Avidity Biosciences, Inc., Amylyx Pharmaceuticals, Alector, Cure Alzheimer's Fund +50 more (view full list) |
| SIC | SIC Code 73 Companies, SIC Code 737 Companies |
| NAICS | NAICS Code 513 Companies, NAICS Code 51 Companies |
Looking for a particular Synapticure Inc. employee's phone or email?
The Synapticure Inc. annual revenue was $21 million in 2026.
Sandra Abrevaya is the CEO and Co-Founder of Synapticure Inc..
66 people are employed at Synapticure Inc..
Synapticure Inc. is based in Chicago, Illinois.
The NAICS codes for Synapticure Inc. are [513, 51].
The SIC codes for Synapticure Inc. are [73, 737].